Nitrofurantoin Dosing Calculation for 36 kg Pediatric Patient
For a 36 kg pediatric patient receiving nitrofurantoin at 7 mg/kg/day divided every 6 hours, administer 63 mg per dose (252 mg total daily dose). This translates to approximately 60-65 mg every 6 hours in clinical practice, depending on available formulation strengths.
Dosing Calculation
Total daily dose:
- 7 mg/kg/day × 36 kg = 252 mg/day
Individual dose (q6h = 4 doses per day):
- 252 mg ÷ 4 doses = 63 mg per dose
Dosing schedule:
- 63 mg PO every 6 hours (at 0600,1200,1800,2400)
Clinical Context and Guideline Support
The 7 mg/kg/day dosing regimen you're using falls within the guideline-recommended range. The 2022 multidrug-resistant organisms guideline specifies nitrofurantoin dosing for pediatrics as 5-7 mg/kg/day PO in 4 divided doses, with a maximum of 100 mg/dose 1. Your prescribed dose of 7 mg/kg/day represents the upper end of this range, which is appropriate for treatment of uncomplicated urinary tract infections.
For this 36 kg patient:
- The calculated 63 mg per dose is well below the 100 mg maximum per dose
- The total daily dose of 252 mg is appropriate for this weight
Important Prescribing Considerations
Indication-specific guidance:
- This dosing is appropriate for uncomplicated cystitis only 1
- Do not use nitrofurantoin for pyelonephritis or perinephric abscess - the oral formulation does not achieve adequate tissue concentrations outside the urinary tract 1, 2
- Nitrofurantoin should not be used for febrile UTIs or systemic infections as it does not achieve therapeutic bloodstream concentrations 2
Duration of therapy:
- Recommended treatment duration is 7 days or at least 3 days after obtaining sterile urine 1
- For uncomplicated cystitis in adults, 5-day courses are effective 3, though pediatric data support 7-10 day courses 4, 5
Critical Safety Warnings
Contraindications to verify before prescribing:
- Renal function: Contraindicated if creatinine clearance <60 mL/min or clinically significant elevated serum creatinine 6
- Age restrictions: Not approved for children <12 years by Taiwan FDA, though widely used off-label with specialist guidance 1
- G6PD deficiency: Screen for glucose-6-phosphate dehydrogenase deficiency, particularly in patients of African, Mediterranean, or Asian descent, as nitrofurantoin can cause hemolytic anemia 6, 7
- Pregnancy: Contraindicated at term and in neonates 6
Monitor for adverse effects:
- Pulmonary reactions (chronic, subacute, or acute) - particularly concerning with prolonged use >6 months 6
- Peripheral neuropathy - risk increased with renal impairment, anemia, diabetes, electrolyte imbalance, or vitamin B deficiency 6
- Hepatic reactions including hepatitis and hepatic necrosis 6
Practical Formulation Considerations
Available formulations typically include:
- 25 mg capsules/tablets
- 50 mg capsules/tablets
- 100 mg capsules/tablets
For 63 mg dosing, practical options:
- Use 50 mg + 25 mg formulations = 75 mg (slightly higher but acceptable)
- Use 50 mg formulation alone = 50 mg (5.6 mg/kg/day, still within guideline range)
- If only 100 mg available, consider reducing total daily dose to 5-6 mg/kg/day to avoid exceeding 100 mg per dose
The slight adjustment to accommodate available formulations is clinically acceptable as the guideline range is 5-7 mg/kg/day 1.